PFE

Pfizer Inc.

PFE · NYQ
Watching
—
Loading prices…
Daily prices

Rank vs the other stocks

Trading model
Hold
69thpercentile
Last 6 sessions
WeakestStrongest

PFE placed in the 69th percentile of the stocks being followed just after the open on . The trading model buys from the top of this list.

Model score
+0.29
Ranked

Old model

Guesses whether the price goes up or down. Latest call: Buy
Not trading
Next day
↑ Up
4% confidence
Next 2 days
↑ Up
25% confidence

Made

Technical signals

Momentum, trend, volatility and volume from recent trading, as of
Momentum
RSI (14)
0.656
Stochastic %K (14)
0.874
Stochastic %D (14)
0.913
Trend
Price vs SMA (20)
0.043
Price vs EMA (26)
0.042
Price vs WMA (20)
0.030
Volatility
Bollinger %B (20/2)
0.848
Bollinger Bandwidth (20/2)
0.124
ATR % (14)
0.019
Volume
OBV change (20)
0.017
Money Flow Index (14)
0.618
Chaikin Money Flow (20)
0.091
Returns & Statistics
Return (1)
−0.013
Return (2)
0.006
Overnight gap
−0.005

Technical signals for PFE

Computed from recent prices and volume, as of . The models read these alongside the other signals. 100% of them have enough price history to compute; a 0 with low coverage usually means "not enough history yet", not a real reading.

Momentum

Oscillators that gauge how strongly and how fast the price has been moving — used to spot overbought/oversold conditions and shifts in drive.

RSI (7)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.6595
RSI (14)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.6561
RSI (21)
Relative Strength Index: 0–1 scale of recent gains vs losses. Above ~0.7 is 'overbought' (may be due to cool off); below ~0.3 'oversold'.
0.6431
Stochastic %K (14)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.8735
Stochastic %D (14)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.9132
Stochastic %K (9)
Where the close sits within its recent high–low range (0 = at the low, 1 = at the high).
0.8225
Stochastic %D (9)
A 3-day smoothing of Stochastic %K — the slower signal line.
0.8878
Stochastic RSI (14)
RSI rescaled to where it sits in its own recent range (0–1) — a more sensitive overbought/oversold reading.
0.7562
Williams %R (14)
Like the Stochastic, the close's position in the recent range (0 = low, 1 = high).
0.8735
CCI (20)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
0.8033
CCI (40)
Commodity Channel Index: how far price is from its average, squashed to about −1…+1. High = unusually strong, low = unusually weak.
0.9359
Rate of Change (5)
Log return over the lookback — simple momentum (positive = up).
0.0151
Rate of Change (10)
Log return over the lookback — simple momentum (positive = up).
0.0600
Rate of Change (20)
Log return over the lookback — simple momentum (positive = up).
0.0463
KDJ %K (9)
Smoothed position of the close in its recent range (0–1).
0.8738
KDJ %D (9)
A further smoothing of KDJ %K.
0.8478
KDJ %J (9)
The fast, sensitive leg of KDJ — exaggerates turns.
0.7286
Ultimate Oscillator (7/14/28)
Buying pressure blended across short, medium and long windows (0–1).
0.5973
True Strength Index (25/13)
Double-smoothed momentum, about −1…+1 (positive = upward drive).
0.3125

Trend

Moving-average and directional measures of which way the price is trending and how strong that trend is.

Price vs SMA (10)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0185
Price vs SMA (20)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0432
Price vs SMA (50)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.0613
Price vs SMA (100)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.1303
Price vs SMA (200)
How far the close is above (+) or below (−) its simple moving average, as a fraction.
0.1470
Price vs EMA (12)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0209
Price vs EMA (26)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0419
Price vs EMA (50)
How far the close is above/below its exponential moving average (weights recent prices more).
0.0670
Price vs EMA (200)
How far the close is above/below its exponential moving average (weights recent prices more).
0.1470
Price vs WMA (20)
How far the close is above/below its weighted moving average.
0.0297
PPO (12/26/9)
Percentage Price Oscillator — MACD expressed as a percent so it compares across stocks. Positive = short-term momentum above long-term.
0.0206
PPO Signal (12/26/9)
The smoothed signal line of the PPO.
0.0151
PPO Histogram (12/26/9)
PPO minus its signal line — momentum of the momentum.
0.0055
ADX (14)
Trend strength on a 0–1 scale (direction-agnostic). Higher = a stronger trend.
0.2865
+DI (14)
Strength of upward directional movement (0–1).
0.3320
−DI (14)
Strength of downward directional movement (0–1).
0.1347
Aroon Up (25)
How recently a new high was made (1 = just now).
0.9600
Aroon Down (25)
How recently a new low was made (1 = just now).
0.4400
Aroon Oscillator (25)
Aroon Up minus Down — positive favours an uptrend.
0.5200
Parabolic SAR distance
How far price is from the trailing stop-and-reverse level, as a fraction of price.
0.0570
Parabolic SAR side
+1 when price is above the SAR (uptrend), −1 below.
1.0000
Vortex +VI (14)
Strength of upward trend movement (centred at 0).
0.2413
Vortex −VI (14)
Strength of downward trend movement (centred at 0).
−0.4134
Vortex difference (14)
+VI minus −VI — positive favours an uptrend.
0.6547
MA slope (50/20)
The recent slope of a moving average (positive = rising trend).
0.0503

Volatility

How much the price is swinging around — wide bands and high readings mean larger, riskier moves.

Bollinger %B (20/2)
Where price sits within its Bollinger Bands (0 = lower band, 1 = upper). Above 1 or below 0 is an extended move.
0.8481
Bollinger Bandwidth (20/2)
How wide the bands are relative to price — bigger means more volatile.
0.1240
ATR % (14)
Average True Range as a percent of price — typical daily swing size.
0.0186
Keltner position (20/10/2)
Where price sits within its Keltner Channel (0–1).
0.9390
Keltner width (20/10/2)
Width of the Keltner Channel relative to price.
0.0781
Donchian position (20)
Where price sits within its recent high–low channel (0–1).
0.8765
Donchian width (20)
Width of the recent high–low channel relative to price.
0.1154
Realized volatility (10)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0138
Realized volatility (20)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0130
Realized volatility (60)
Standard deviation of recent daily returns — how jumpy the stock has been.
0.0123
Chaikin Volatility (10/10)
Whether the daily high–low range is expanding (+) or contracting (−).
−0.0951
Ulcer Index (14)
A drawdown-based stress measure — higher means deeper/longer dips from recent highs.
5.4633

Volume

Whether trading activity is confirming the price move — money flowing in or out, and unusually heavy or light volume.

OBV change (20)
On-Balance Volume trend — net volume flowing in (+) or out (−).
0.0170
Money Flow Index (14)
A volume-weighted RSI (0–1). High = strong buying pressure.
0.6181
Chaikin Money Flow (20)
Buying vs selling pressure weighted by volume (−1…+1).
0.0910
Money Flow Multiplier
Where the close finished in the bar's range, the building block of accumulation/distribution (−1…+1).
−0.1373
Accum/Dist change (20)
Recent change in the Accumulation/Distribution line (buying vs selling pressure).
0.0910
Price vs VWAP (20)
How far the close is above/below the rolling volume-weighted average price.
0.0451
Force Index (13)
Return times relative volume — the push behind a move.
−0.0129
Ease of Movement (sign) (14)
+1 when price rose easily on light volume, −1 when it fell easily.
−1.0000
Ease of Movement (z) (14)
How unusual today's ease-of-movement is vs recent days.
−0.9904
Volume Rate of Change (14)
Log change in volume vs n days ago — a volume surge/lull.
−0.1135
Volume Rate of Change (25)
Log change in volume vs n days ago — a volume surge/lull.
−0.9422
Relative Volume (z) (20)
How many standard deviations today's volume is above/below its recent average.
−0.0331
Relative Volume (z) (50)
How many standard deviations today's volume is above/below its recent average.
−0.2827
Relative Volume (20)
Today's volume vs its recent average (log scale; >0 = above).
−0.0072
Relative Volume (50)
Today's volume vs its recent average (log scale; >0 = above).
−0.0879

Returns & Statistics

Recent returns over several horizons plus statistical shape (skew, fat tails, drawdown, risk-adjusted return).

Return (1)
Log return over the horizon (positive = up).
−0.0129
Return (2)
Log return over the horizon (positive = up).
0.0060
Return (3)
Log return over the horizon (positive = up).
−0.0027
Return (5)
Log return over the horizon (positive = up).
0.0151
Return (10)
Log return over the horizon (positive = up).
0.0600
Return (20)
Log return over the horizon (positive = up).
0.0463
Overnight gap
Open vs the prior close — overnight move.
−0.0046
Intraday range
High minus low as a fraction of price — the day's swing.
0.0170
True range
True range (gap-aware swing) as a fraction of price.
0.0203
Return skew (20)
Asymmetry of recent returns — negative means crash-prone tails.
0.5556
Return skew (60)
Asymmetry of recent returns — negative means crash-prone tails.
0.2713
Return kurtosis (20)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
−0.6674
Return kurtosis (60)
Fat-tailedness of recent returns — high means jumpy/extreme moves.
−0.2543
Downside deviation (20)
Volatility of only the negative returns — pure downside risk.
0.0067
Downside deviation (60)
Volatility of only the negative returns — pure downside risk.
0.0066
Max drawdown (20)
Largest peak-to-trough drop over the window, as a fraction.
0.0456
Max drawdown (60)
Largest peak-to-trough drop over the window, as a fraction.
0.0555
Return/risk (20)
Average return divided by its volatility — recent risk-adjusted return.
0.1785
Return/risk (60)
Average return divided by its volatility — recent risk-adjusted return.
0.2524
Return persistence (20)
Whether up days tend to follow up days (+) or reverse (−).
−0.1118
Return persistence (60)
Whether up days tend to follow up days (+) or reverse (−).
0.0197
Price z-score (20)
How many standard deviations the price is from its recent average.
1.3571
Price z-score (50)
How many standard deviations the price is from its recent average.
2.1452
Return z-score (20)
How unusual the latest return is vs recent returns.
−1.1722
Return z-score (50)
How unusual the latest return is vs recent returns.
−1.2434

Latest signals

Loading signals…

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the… Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYQ
Currency
USD

News

No recent news about PFE.

Locations

Where the company has offices, plants and other sites. Used to judge supply-chain and regional risk.